05/2012–12/2015 PhD in Biochemistry and Molecular Biology, Department of Chemistry,
University of Patras, Patras, Greece
10/2010–04/2012 Masters in Applied Biochemistry: Clinical chemistry,
Biotechnology and Evaluation of Pharmaceutical Products,
Department of Chemistry, University of Patras, Patras, Greece
09/2006–09/2010 Bachelor in Chemistry, University of Patras, Patras, Greece
PREVIOUS RESEARCH POSITIONS
12/2019-11/2021 Senior Postdoctoral Fellow, Department of Biological Regulation,
Weizmann Institute of Science, Israel
12/2016-12/2019 Postdoctoral Fellow, Department of Biological Regulation,
Weizmann Institute of Science, Israel
01/2016-11/2016 Postdoctoral Fellow, Biotech Research & Innovation Centre,
Copenhagen University, Copenhagen, Denmark
01/2014–12/2014 Visiting Fellow Scientist, Biotech Research & Innovation Centre,
Copenhagen University, Copenhagen, Denmark
2019 Senior Postdoctoral Fellowship, Feinberg Graduate School,
Weizmann Institute of Science, Rehovot, Israel.
2017 Dean of Faculty Postdoctoral Fellowship, Feinberg Graduate School,
Weizmann Institute of Science, Rehovot, Israel.
2016 FEBS short-term fellowship
2015 EMBO short-term fellowship
2014 Short-term fellowship, State Scholarships Foundation (IKY)
2013 FEBS Bursary, 38th FEBS Conference, St. Petersburg, Russia
2012 Scholarship for doctoral studies under Research Funded Project:
THALES co-financed by the European Union
(European Social Fund - ESF) and national fund through the
Operational Program "Education and Lifelong Learning"
of the National Strategic Reference Framework (NSRF)
2012 FEBS Bursary, 22ο IUBMB & 37ο Συνέδριο της FEBS, Sevilla, Spain.
HONORS AND AWARDS
2023 European Registered Toxicologist (ERT) - EUROTOX
2019 Boehringer Ingelheim Stiftung (BIS) travel grant, EMBO-FEBS Lecture course
“Molecular mechanisms of Tissue Injury, Repair and Fibrosis”, Spetses, Greece.
Title: Development of protein-based inhibitors against LOX family in fibrotic diseases.
2019 FEBS Youth Travel Funds, 7th Matrix Pathobiology, Signaling and Molecular Targets,
Porto Heli, Greece, 2019.
Title: Targeting lysyl oxidase fibrotic actions with selective protein-based inhibitors.
2018 Seal of excellence, Marie Sklodowska-Curie actions for postdoctoral research.
Horizon 2020, European Commission.
Title: Targeting Lysyl Oxidase for successful treatment of Duchenne muscular dystrophy
2018 Young Scientist Award, 1st FEBS-MPST Advanced Lecture Course ECM:
Cell regulation, Epigenetics & Modeling, Patras, Greece.
Title: Promoting native cell-derived activated MMPs (collagenases) by using
Lysyl Oxidase (LOX) inhibitors to resolve fibrotic tissues.
2017 Travel grant from International Society of Matrix Biology for the 6th FEBS-MPST
Advanced Lecture Course on Matrix Pathobiology, Signaling and
Molecular Targets, Spetses, Greece.
Title: IGF-IR inhibits breast cancer cells aggressiveness via regulation of syndecan-4
and MMPs expression.
2016 Award from Matrix Biology Section of Hellenic Society of Biochemistry
and Molecular Biology, Dick Heinegard European Young Investigation Award
Title: Syndecan-4 is a key modulator of epithelial-to-mesenchymal transition
in breast cancer cells.
2014 FEBS Journal top-cited Paper award
Title: Glycosaminoglycans: key players in cancer cell biology and treatment.
- COMPOSITIONS COMPRISING THE PROPEPTIDE OF LYSYL OXIDASE AND USES THEREOF. Filed: PCT/US: 62/977,792; PCT/IL2020/050486
- BI-SPECIFIC INHIBITION OF LOX AND HSP70 MELANOMA REDUCES METASTASIS AND ACTIVATES IMMUNE SYSTEM, U.S. Patent Application No. 63/311,047 and filed on February 17, 2022
- ANTI-KLK4 ANTIBODIES AND USES THEREOF, US Provisional Patent Application No. 63/405,446 Filed on September 11, 2022
(Last updated: May 8, 2023)